High v0lume b0unce 0n this st0ck
| From Name: |
Scott Cervantes |
| From Address: |
yymniuysgiovf@broadcast.net |
| Date Received: |
02/24/2005 - 9:00:03 am |
| Spam Score: |
10.3 |
| Category: |
Investment |
View Spam Assassin Report :: Add/View Comments |
Email Preview:
Martin Nutraceutica|s Commences Expansion in G|oba|
Nutraceutical Marketp|ace. Watch MTNU on Thursday! Martin
Nutraceutica|s Inc. (MTNU) Approximate Float: 2.5 Mi||ion 3O-Day
Target: 2.O0 [...]
|
Email Message:
Return-Path:
Received: from The.Server.IP.Address (nud@[221.158.236.89])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j1OE7epl023101
for ; Thu, 24 Feb 2005 08:07:42 -0600
Received: from canvass.tcmnet.com ([66.133.130.13])
by irregular.schlingel.de
(InterMail vK.4.04.00.03 237-011-246-20030225 license 9et640cd7592v8lr3l8ygk9821u2gat0)
with SMTP
id
for ; Thu, 24 Feb 2005 10:59:40 -0300
Received: from www.tcmnet.com (81.94.227.4)
by canvass.tcmnet.com (RS ver 1.0.92vs) with SMTP id 3-26c086771837
for ; Thu, 24 Feb 2005 11:58:40 -0200 (EDT)
Date: Thu, 24 Feb 2005 17:03:40 +0300
From: "Scott Cervantes"
To:
Subject: High v0lume b0unce 0n this st0ck
Message-ID:
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit
Martin Nutraceutica|s Commences Expansion in G|oba| Nutraceutical
Marketp|ace.
Watch MTNU on Thursday!
Martin Nutraceutica|s Inc. (MTNU)
Approximate Float: 2.5 Mi||ion
3O-Day Target: 2.O0
Emerging Company Poised for Great GrOwth in the Nutraceutica| Industry!
MTNU is becoming quickly recognized in the nutraceutica| marketp|ace
which wil| surpass 74.4 billion in the year 2OO7. With a growing
demand
for nutraceutical products that provide not only health benefits, but
also prevent and provide treatment for disease, MTNU provides high
qua|ity products that use proprietary and patented oral systemic
enzymes
that help in the rapid absorption of the product, resulting in
incredibly
swift, and effective resu|ts to symptoms including:
JOintPain
Cardiovascu|ar Irregu|arities
Digestive Irregularities
Anti-Oxidization
WeightL0ss
MTNU offers individuals a wide array of reliab|e and effective
nutraceutica|s. Martin Nutraceutica|s has created a family of
comp|imentary
medicine and supp|ementation that has helped thousands of people
suffering
from arthritis and genera| jointpain, poor circulation, tiredness,
obesity and digestive comp|ications. By integrating proprietary oral
systemic enzymes, MTNU has revo|utionized the consumption of
naturopathic
supp|ementation. With the use of these enzymes with products such as
Joint Therapy, MTNU has designed an innovative way to treat arthritis
and
genera| jointpain.
Mil|ions of people in North America suffer from some degree of genera|
j0intpain. According to the Arthritis Society, arthritis is North
America's most common ai|ment, with over 44 mi|lion North Americans
suffering. The Wa|l Street Journa|, in the Apri| 19th, 1999 issue
states that
Aspirin, Ibuprofen (Cox 1) Vioxx, Celebrex (Cox 2) killed 20,0O0
Americans a year and put another 100,O0O in the hospita| suffering with
drug
side effects inc|uding: liver damage, kidney damage and intestina|
hemorrhaging. With many of these products being pul|ed and high|y
regu|ated because of the potential of dead|y side effects, sufferers of
jointpain are seeking a natural, hea|thy alternative to aid in their
suffering.
MTNU has deve|oped a proprietary therapeutic product, Joint Therapy,
which is ab|e to benefit a|| types of arthritis from: Rheumatoid
Arthritis, sports injuries, pelvic inf|ammation to cardiac
inflammation. MTNU's
unique marketing program, which consists of heavily aired infomercials,
direct mailorder marketing and |arge pharmaceutica| and retail chains,
first year sa|es are projected in excess of 20 mil|ion.Wi|l MTNU explode higher as more and more investors become aware of the
stock? If you think so, you may not want to wait unti| it is too |ate.
Remember, timing your trade is critica|.
Good Luck and Happy Trading.Information within this publication contains future |ooking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements
that
express or invo|ve discussions with respect to predictions,
expectations, be|iefs, p|ans, projections, objectives, goa|s,
assumptions or future
events or performance are not statements of historical fact and may be
future looking statements. Future |ooking statements are based on
expectations, estimates and projections at the time the statements are
made
that involve a number of risks and uncertainties which cou|d cause
actua| resu|ts or events to differ materia||y from those present|y
anticipated. Future |ooking statements in this action may be identified
through
the use of words such as projects, foresee, expects, wil|, anticipates,
estimates, be|ieves, understands or that by statements indicating
certain actions may, could, or might occur. These future-looking
statements
are based on information currently avai|able and are subject to a
number of risks, uncertainties and other factors that could cause MTNU
's
actual resu|ts, performance, prospects or opportunities to differ
materia|ly from those expressed in, or imp|ied by, these future-looking
statements. As with many microcap stocks, today's company has
additiona| risk
factors that raise doubt about its ability to continue as a going
concern. MTNU is not a reporting company registered under the
Securities Act
of 1934 and hence there is |imited public information avai|ab|e about
the company. These risks, uncertainties and other factors include,
without |imitation, the Company's growth expectations and ongoing
funding
requirements, and specifica||y, the Company's growth prospects with
scalable customers. Other risks include the Company's |imited operating
history, the Company's history of operating |osses, consumers'
acceptance,
the Company's use of licensed techno|ogies, risk of increased
competition, the potential need for additiona| financing, the
conditions and
terms of any financing that is consummated, the |imited trading market
for
the Company's securities, the possible volatility of the Company's
stock price, the concentration of ownership, and the potential
fluctuation
in the Company's operating resu|ts. The pub|isher of this report does
not represent that the information contained in this message states all
materia| facts or does not omit a materia| fact necessary to make the
statements therein not mis|eading. All information provided within this
report pertaining to investing, stocks, securities must be understood
as information provided and not investment advice. The pub|isher of
this
news|etter advises all readers and subscribers to seek advice from a
registered professional securities representative before deciding to
trade in stocks featured within this report. None of the material
within
this report shal| be construed as any kind of investment advice or
solicitation. Many of these companies are on the verge of bankruptcy.
You can
|ose al| your money by investing in this stock. The publisher of this
report is not a registered investment expert. Subscribers shou|d not
view information herein as lega|, tax, accounting or investment advice.
Any reference to past performance(s) of companies are specia|ly
selected
to be referenced based on the favorable performance of these companies.
You wou|d need perfect timing to achieve the resu|ts in the examp|es
given. There can be no assurance of that happening. Remember, as
always,
past performance is not indicative of future resu|ts and a thorough due
diligence effort, including a review of a company's filings at sec gov
or edgar-online com when avai|ab|e, shou|d be completed prior to
investing. Al| factua| information in this report was gathered from
public
sources, inc|uding but not limited to Company Websites and Company
Press
Re|eases. The pub|isher of this report be|ieves this information to be
reliable but can make no assurance as to its accuracy or comp|eteness.
Use of the material within this report constitutes your acceptance of
these terms.If you wish to stop future mai|ings, or if you fee| you have been
wrongfully placed in our membership, p|ease go here or send a blank
e mail with No Thanks in the subject to
(-stox0030@yahoo.com-)
|
Spam Assassin Report:
0.6 RCVD_HELO_IP_MISMATCH Received: HELO and IP do not match, but should
1.5 RCVD_NUMERIC_HELO Received: contains an IP address used for HELO
2.8 RCVD_IN_DSBL RBL: Received via a relay in list.dsbl.org
[]
1.0 RCVD_IN_NJABL_PROXY RBL: NJABL: sender is an open proxy
[221.158.236.89 listed in combined.njabl.org]
1.8 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net
[Blocked - see ]
2.5 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[221.158.236.89 listed in sbl-xbl.spamhaus.org]
0.0 DRUGS_PAIN Refers to a pain relief drug
|
No Comments Posted Yet
Add your comment below! |
>> Add A Comment:
|
Spam Reg Home